[Pe-009] Neuroimmunology (MS and clinical research2)

[Pe-009-2] Clinical feature of MOG-IgG+ disorder in Japan; survey of 369 pediatric and adult cases

^○Kimihiko Kaneko¹, Douglas Kazutoshi Sato^1,2, Ryo Ogawa¹, Tetsuya Akaishi³, Yoshiki Takai¹, Shuhei Nishiyama¹, Tatsuro Misu¹, Toshiyuki Takahashi^1,3, Hiroshi Kiuroda¹, Ichiro Nakashima^1,4, Kazuo Fujihara^1,5,6, Masashi Aoki¹ (1.Department of Neurology, Tohoku University, Sendai, Japan, 2.Brain Institute and Hospital Sao Lucas Pontificial Catholic University of Rio Grande do Sul, Port alegre, Brazil, 3.Department of neurology, Yonezawa National Hospital, Yonezawa, Japan, 4.Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 5.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan, 6.Multiple Sclerosis and Neuromyelitis Optica Center, TOHOKU Research Institute for Neuroscience, Koriyama, Japan)